Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Nosa Plugs

0.53 SEK

-5.53 %

Less than 1K followers

NOSA

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
-5.53 %
-22.17 %
-28.09 %
-35.99 %
-43.01 %
-29.33 %
+83.39 %
-88.77 %
-97.05 %

Nosa Plugs operates in the medical technology sector. The company is a developer of intranasal breathing products. The product range is broad and includes, for example, odor protection, nasal filters against airborne allergens and nasal protection used to reduce viruses and bacteria. The products are used, for example, by people who suffer from various allergies. The largest operations are found in the Nordic market, with the headquarters located in Stockholm.

Read more
Market cap
137.89M SEK
Turnover
133.74K SEK
Revenue
16.1M
EBIT %
-64.1 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
13.2
2026

Annual report '25

8.5
2026

General meeting '26

15.5
2026

Interim report Q1'26

All
Press releases
3rd party
ShowingAll content types
Press release8/27/2025, 1:52 PM

Carlsquare: Equity research Nosa Plugs Q2, 2025: Growth ahead but mixed results in Q2

Nosa Plugs
Press release7/11/2025, 1:42 PM

Carlsquare: Mrkt BUZZ, Nosa Plugs: Positive results and proof of concept

Nosa Plugs
Press release6/16/2025, 5:00 PM

Carlsquare: Mrkt BUZZ, Nosa Plugs: First possible acquisition announced

Nosa Plugs

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release5/21/2025, 1:20 PM

Carlsquare: Equity research Nosa Plugs Q1, 2025: NOSA starting 2025 with consistent growth

Nosa Plugs
Third party research5/15/2025, 8:50 AM

Analyst Group Comment on Nosa Plugs Q1 Report

Nosa Plugs AB (“Nosa Plugs” or the “Company”) published the Company’s interim report for the first quarter of 2025 on May 15, 2025, which demonstrated continued strong operational development with high growth and improved profitability.

Nosa Plugs
Third party research4/2/2025, 9:25 AM

Analyst Group Comments on Nosa Plugs Achieving Positive Cash Flow in Q1 2025

Nosa Plugs AB (“Nosa Plugs” or “the Company”) announced on April 2, 2025, that it has reached its target of achieving positive cash flow during the first quarter of 2025. This has been accomplished through strong growth in recent years and continued ...

Nosa Plugs
Press release4/2/2025, 8:03 AM

Carlsquare: Mrkt BUZZ, Nosa Plugs: Cash flow in the black, goal achieved

Nosa Plugs
Third party research3/25/2025, 7:52 AM

Analyst Group Comments on Nosa Plugs’ Launch of NOSA Nozoil in Germany

Nosa Plugs AB (“Nosa Plugs” or “the Company”) announced on March 24, 2025, that the Company is launching NOSA Nozoil Original and NOSA Nozoil Menthol, a moisturizing nasal spray designed for individuals with dry nasal mucosa, on the German pharmacy market...

Nosa Plugs
Third party research2/20/2025, 9:09 AM

Nosa Plugs: The Expansion Continues - Analyst Group

Nosa Plugs AB ("Nosa Plugs" or the "Company") is a medical technology company that has developed intranasal breathing products for applications such as odor protection and olfactory training, achieving strong historical growth with a 36% CAGR between...

Nosa Plugs
Press release2/20/2025, 8:30 AM

Carlsquare: Equity Research Update NOSA Q4 2024: Strong growth and announced M&A strategy

Nosa Plugs
Third party research2/14/2025, 11:32 AM

Analyst Group Comment on Nosa Plugs Q4-report

On February 14, 2025, Nosa Plugs published the company’s interim report for the fourth quarter of 2024.

Nosa Plugs
Press release2/14/2025, 7:50 AM

Carlsquare: First impression Nosa Plugs Q4, 2024: ending the year with strong growth

Nosa Plugs
Press release12/19/2024, 11:20 AM

Carlsquare: Mrkt BUZZ Nosa Plugs: Drug Delivery patent submitted

Nosa Plugs
Press release11/19/2024, 9:13 AM

Carlsquare: Equity research Nosa Plugs Q3, 2024: Strong growth with rise in valuation on the cards

Nosa Plugs
Press release11/8/2024, 8:22 AM

Carlsquare: First impression Nosa Plugs Q3, 2024: Stronger sales than expected

Nosa Plugs
Press release8/29/2024, 12:40 PM

Carlsquare: Equity research Nosa Plugs Q2, 2024: A second quarter with significant news flow

Nosa Plugs
Press release8/23/2024, 7:00 AM

Carlsquare: First impression Nosa Plugs Q2, 2024: Record breaking sales and gross margin

Nosa Plugs
Press release6/20/2024, 1:40 PM

Carlsquare: Mrkt BUZZ Nosa Plugs: New orders and distributor agreements

Nosa Plugs
Press release5/17/2024, 11:05 AM

Carlsquare: Equity Research Update NOSA Q1, 2024: Tepid Q1 and updated company strategy

Nosa Plugs
Press release2/21/2024, 8:10 AM

Carlsquare: Equity Research Update NOSA Q4, 2023: Record-breaking sales funding the pipeline

Nosa Plugs
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.